Skip to content
Recall Observatory FDA recall evidence

Drug product

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

D-1269-2020

April 14, 2020

Class I

Product summary

Firm
MasterPharm LLC
Event
Event 85619
Status
Terminated
Classification
Class I
Quantity
7260 capsules
Official record key
drug-enforcement:D-1269-2020

Official wording

Reason: Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Code information: Lot #02-27-2020:04@11, Exp. August 25, 2020.

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.